Brazilian pharmaceutical manufacturer focused on cardiovascular, diabetes, and generic drugs
Torrent do Brasil operates a 42-product pharmaceutical portfolio positioned as the 13th largest by prescription revenue in Brazil, with over 50 years of parent-company history in India and presence across 40+ countries. Active hiring across marketing, finance, and healthcare—with acceleration in the last 30 days—reflects growth, but the tech stack (Excel, SAP, Power BI, Tableau, IQVIA) and project priorities (demand forecasting, inventory optimization, budget accuracy, regulatory compliance) reveal a business still reliant on manual workflows and spreadsheet-heavy analytics; the absence of any modern data or automation tooling suggests significant runway for operational modernization.
Torrent do Brasil manufactures and distributes pharmaceutical products across three main therapeutic areas: cardiovascular treatment, diabetes management, and generic medications. The company serves Brazilian healthcare providers, pharmacies, and patients through a field sales model involving doctor and pharmacy visitation. With 501–1,000 employees in São Paulo, the company combines commercial distribution with manufacturing operations, supported by regulatory, demand planning, and marketing functions. The portfolio of 42 SKUs and ranking as Brazil's 13th pharmaceutical company by prescription revenue position it as a mid-tier national player with established healthcare relationships.
SAP (ERP), Power BI and Tableau (analytics), Excel and VBA (spreadsheet modeling), SharePoint (collaboration), and IQVIA (market intelligence).
Cardiovascular, diabetes, central nervous system treatments, and generic medications. The portfolio includes 42 products distributed across Brazilian healthcare and pharmacy channels.
Other companies in the same industry, closest in size